Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy

PURPOSE: To explore the effect and potential mechanism of dihydroartemisinin (DHA) on metabolism-related fatty liver disease. METHODS: A metabolic associated fatty liver disease (MAFLD) mice model was induced with continuous supplies of high-fat diet. DHA was intraperitoneally injected into mice. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yiyi, Peng, Xuetao, Du, Guoping, Zhai, Yingji, Xiong, Xingbo, Luo, Xiaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578105/
https://www.ncbi.nlm.nih.gov/pubmed/37851788
http://dx.doi.org/10.1590/acb385023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578105/
https://www.ncbi.nlm.nih.gov/pubmed/37851788
http://dx.doi.org/10.1590/acb385023

Ejemplares similares